Publications by authors named "May Levin"

Claim this Profile
C
Comparability of venous and capillary blood measurements for a host-protein test differentiating bacterial from viral infections.
Mary Hainrichson, Nitzan Shamir, Naftalie Senderovich, May Levin, Husein Darawsha

Clin Biochem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introducing a foundational sequence transformer for range adaptive nucleotide decoding (STRAND).
Shant Ayanian, Collin Osborne, Clark Xu, Carl Molnar, Pravat Das, May Levin

Brief Bioinform· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine Learning Strategies for Improved Phenotype Prediction in Underrepresented Populations.
David Bonet, May Levin, Daniel Mas Montserrat, Alexander G Ioannidis

Pac Symp Biocomput· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine Learning Strategies for Improved Phenotype Prediction in Underrepresented Populations.
David Bonet, May Levin, Daniel Mas Montserrat, Alexander G Ioannidis

bioRxiv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-differentiated incentives for adaptive behavior during epidemics produce oscillatory and chaotic dynamics.
Ronan F Arthur, May Levin, Alexandre Labrogere, Marcus W Feldman

PLoS Comput Biol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Folylpolyglutamate synthetase mRNA G-quadruplexes regulate its cell protrusion localization and enhance a cancer cell invasive phenotype upon folate repletion.
Michal Stark, May Levin, Igor Ulitsky, Yehuda G Assaraf

BMC Biol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance.
May Levin, Michal Stark, Yishai Ofran, Yehuda G Assaraf

Cancer Cell Int· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine.
May Levin, Michal Stark, Bluma Berman, Yehuda G Assaraf

Cell Death Dis· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The JmjN domain as a dimerization interface and a targeted inhibitor of KDM4 demethylase activity.
May Levin, Michal Stark, Yehuda G Assaraf

Oncotarget· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Techniques and methods in public health applied in oncology].
F May-Levin, F Clavel, J Monsonego, H Tristant, L Levy

Bull Cancer· January 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Cancer chemotherapy. The price to pay].
F May-Levin

Soins· May 1997

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a polyclonal antibody for the determination of the prognostic value of c-erbB-2 protein over-expression in human breast cancer.
P Terrier, H Mouriesse, B Loridon, M Gotteland, F May-Levin

Acta Oncol· June 1996

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pamidronate infusions as single-agent therapy for bone metastases: a phase II trial in patients with breast cancer.
C T Tyrrell, P F Bruning, F May-Levin, C Rose, L Mauriac

Eur J Cancer· November 1995

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the negative prognostic value of high oestrogen receptor (ER) levels in postmenopausal breast cancer patients due to a modified ER gene product?
H Sancho-Garnier, J C Delarue, H Mouriesse, G Contesso, F May-Levin

Eur J Cancer· October 1995

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined overexpression of c-erbB-2 protein and epidermal growth factor receptor (EGF-R) could be predictive of early and long-term outcome in human breast cancer: a pilot study.
J C Delarue, P Terrier, M J Terrier-Lacombe, H Mouriesse, M Gotteland, F May-Levin

Bull Cancer· December 1994

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial of continuous infusion vinorelbine for advanced breast cancer.
C Toussaint, J Izzo, M Spielmann, S Merle, F May-Levin

J Clin Oncol· October 1994

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptors (ER) in human breast cancer. The significance of a new prognostic factor based on both ER protein and ER mRNA contents.
M Gotteland, E May, F May-Levin, G Contesso, J C Delarue

Cancer· August 1994

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical and chemotherapeutic treatment of hepatic metastases from carcinoma of the breast.
D Elias, P Lasser, M Spielmann, F May-Levin, O el Malt

Surg Gynecol Obstet· June 1991

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternating radiotherapy and chemotherapy in non-metastatic inflammatory breast cancer.
R Arriagada, H Mouriesse, M Spielmann, A Mezlini, P Oudinot, F May-Levin

Int J Radiat Oncol Biol Phys· November 1990

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human breast cancer: identification of populations with a high risk of early relapse in relation to both oestrogen receptor status and c-erbB-2 overexpression.
E May, H Mouriesse, F May-Levin, J F Qian, P May

Br J Cancer· September 1990

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Should removal of the ovaries be considered in the treatment of breast cancer in 1989?].
F May-Levin, C Hill, F Fontaine, R Arriagada

Bull Cancer· March 1990

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new approach allowing an early prognosis in breast cancer: the ratio of estrogen receptor (ER) ligand binding activity to the ER-specific mRNA level.
E May, H Mouriesse, F May-Levin, G Contesso, J C Delarue

Oncogene· August 1989

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Enzymo-immunoassay of progesterone receptors in human breast lesions and tumors. Comparison with a biochemical method].
J C Delarue, F Bertin, F May-Levin, H Mouriesse

Bull Cancer· July 1989

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human breast tumors: a comparison between the biochemical method of measuring estrogen and progesterone receptors and that of an immunohistochemical method.
M J Lacombe, J C Delarue, H Mouriesse, G Contesso, S Friedman, F May-Levin

Gynecol Oncol· February 1989

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of mitozolomide (M & B 39,565) in colorectal and breast cancer.
P Herait, P Rougier, J Oliveira, F M Delgado, F May-Levin

Invest New Drugs· December 1988

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis